Your ultimate osteopathy resource on the net


Chronic Kidney Disease: More Common Than You Think

Katherine, a mother of two from theThe change worked for Katherine. Instead
suburbs of Orlando, Florida, wasof the 12 tablets she was taking per day
diagnosed with type 2 diabetes shortlyon a previous phosphate binder,
after her 30th birthday. Two decadesKatherine now takes fewer than five
later, her diabetes led to kidneytablets a day.
failure. Unfortunately, this scenario isThe new medication has enabled Katherine
not uncommon, as diabetes is the leadingto consistently maintain her phosphorus
cause of kidney failure in the Unitedlevels within the recommended
States, accounting for nearly half ofguidelines. Katherine's new binder also
the people who begin treatment eachis a chewable tablet, which she prefers,
year.because like all dialysis patients, she
When the kidneys stop working normally,needs to restrict the amount of water
it is called chronic kidney diseaseshe drinks each day. While Katherine has
(CKD). In Katherine's case, the diseasenot experienced any side effects related
advanced to its most severe form, CKDto FOSRENOL(R), her doctor did advise
Stage 5, which occurs when an individualher that individuals taking the
has lost at least 85 percent of his ormedication may experience nausea or
her kidney function and begins dialysis.vomiting, which generally lessen over
Of the 20 million Americans who havetime as patients continue with their
some form of kidney disease, more thantreatment.
530,000 are on dialysis. DialysisThanks to dialysis, diet and her newly
performs tasks that healthy kidneys do,prescribed phosphate binder therapy,
such as remove wastes, control excessKatherine is successfully managing her
salt and water balance, and maintainhealth and staying active. On most days,
blood pressure.she can be found in her swimming pool
The overall management of kidney diseasewith her children and grandchildren.
is challenging and can lead to a varietyThis patient account reflects one
of additional problems. In Katherine'sperson's experience with
case, she developed hyperphosphatemiahyperphosphatemia, CKD Stage 5 and her
(hi-per-FOS-fuh-TE-me-uh)-high levels oftreatment with FOSRENOL(R). This
phosphorus in the blood-which can leadinformation is not intended as a
to serious long-term health problemssubstitute for medical advice.
over time, such as mineral deposits inNote to Editors: Important Safety
the heart and blood vessels, boneInformation: During clinical trials, the
disease and even death.most common side effects of FOSRENOL(R)
Fortunately, there are treatmentswere gastrointestinal, and included
available to help patients control theirnausea, vomiting, and diarrhea. Nausea
kidney disease and limit the impact ofand vomiting generally lessened over
hyperphosphatemia. Through a combinationtime as patients continued with their
of dialysis, diet and phosphate bindertreatment. Patients who stopped
therapy, patients can manage theirtreatment usually reported
phosphorus levels. In addition to goinggastrointestinal side effects as the
to dialysis three times a week,reason for stopping. Other side effects
Katherine follows a diet that limitsreported in trials included dialysis
foods high in phosphorus, such as dairygraft complications, headache, abdominal
products and dark soda. But phosphoruspain, and low blood pressure. Although
is found in most foods, so patientsstudies were not designed to detect
often cannot reach target blooddifferences in risk of bone fracture and
phosphorus levels through dietarymortality, there were no differences
restriction and dialysis alone. Manydemonstrated in patients treated with
patients, including Katherine, need toFOSRENOL(R) compared to alternative
take phosphate binders at meals andtherapy for up to 3 years. The duration
snacks to help further control theirof treatment exposure and time of
phosphorus levels. Phosphate binders areobservation in the clinical program were
prescription medications which "soak up"too short to conclude that FOSRENOL(R)
phosphorus in the gastrointestinal tractdoes not affect the risk of bone
before it can be absorbed into thefracture or mortality beyond 3 years.
blood, thereby helping patients maintainWhile lanthanum has been shown to
target blood phosphorus levels.accumulate in the GI tract, liver, and
Because phosphate binders need to bebone in animals, the clinical
taken with each meal, finding ansignificance in humans is unknown. If
effective binder that fits eachyou suffer from acute stomach ulcer,
individual patient's needs can becolon inflammation and colon ulcers,
challenging. In April 2005, a member ofCrohn's disease, or bowel obstruction,
Katherine's health care team recommendedit is important to know that patients
that she change her phosphate binder towith these conditions were not included
FOSRENOL(R) because it could reduce thein FOSRENOL(R) clinical studies-please
number of tablets she had to take eachdiscuss with your doctor.
day.



1 A B C 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103